Skip to main content

Advertisement

Log in

A marine-derived Streptomyces sp. MS449 produces high yield of actinomycin X2 and actinomycin D with potent anti-tuberculosis activity

  • Biotechnological products and process engineering
  • Published:
Applied Microbiology and Biotechnology Aims and scope Submit manuscript

Abstract

In the course of our screening program for anti-Mycobacterium bovis bacillus Calmette-Guérin (BCG) and anti-Mycobacterium tuberculosis H37Rv (MTB H37Rv) agents from our marine natural product library, a newly isolated actinomycete strain, designated as MS449, was picked out for further investigation. The strain MS449, isolated from a sediment sample collected from South China Sea, produced actinomycin X2 and actinomycin D in substantial quantities, which showed strong inhibition of BCG and MTB H37Rv. The structures of actinomycins were elucidated by nuclear magnetic resonance and mass spectrometric analysis. The strain MS449 was taxonomically characterized on the basis of morphological and phenotypic characteristics, genotypic data, and phylogenetic analysis. The 16S rRNA gene sequence of the strain was determined and a database search indicated that the strain was closely associated with the type strain of Streptomyces avermitilis (99.7 % 16S rRNA gene similarity). S. avermitilis has not been previously reported to produce actinomycins. The marine-derived strain of Streptomyces sp. MS449 produced notably higher quantities of actinomycin X2 (1.92 mg/ml) and actinomycin D (1.77 mg/ml) than previously reported actinomycins producing strains. Thus, MS449 was considered of great potential as a new industrial producing strain of actinomycin X2 and actinomycin D.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Ashforth EJ, Fu CZ, Liu XY, Dai HQ, Song FH, Guo H, Zhang LX (2010) Bioprospecting for antituberculosis leads from microbial metabolites. Nat Prod Rep 27:1709–1719

    Article  CAS  Google Scholar 

  • Bian J, Song FH, Zhang LX (2008) Strategies on the construction of high-quality microbial natural product library—a review. Acta Microbiol Sin 48:1132–1137

    CAS  Google Scholar 

  • Cowley SC, Av-Gay Y (2001) Monitoring promoter activity and protein localization in Mycobacterium spp using green fluorescent protein. Gene 264:225–231

    Article  CAS  Google Scholar 

  • Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC (1999) Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. J Am Med Assoc 282:677–686

    Article  CAS  Google Scholar 

  • EI-Naggar MYM (1998) Synergistic effect of actinomycin X2 produced by Streptomyces nasri YG62 with other antibiotics. Biomed Lett 58:169–173

    Google Scholar 

  • Felsenstein J (1985) Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39:783–791

    Article  Google Scholar 

  • Fosto S, Mahmud T, Zabriskie TM, Santosa DA, Proteau PJ (2008) Rearranged and unrearranged angucyclinones from Indonesian Streptomyces spp. J Antibiot 61:449–456

    Article  Google Scholar 

  • Green DM (1997) Wilm’s tumour. Eur J Cancer 33:409–418

    Article  CAS  Google Scholar 

  • Henry MS (1985) Actinomycin and DNA transcription. Proc Natl Acad Sci 82:5328–5331

    Article  Google Scholar 

  • Hollstein U (1974) Actinomycin, chemistry and mechanism of action. Chem Rev 74:625–652

    Article  CAS  Google Scholar 

  • Kurosawa K, Buim VP, VanEssendelft JL, Willis LB, Lessard PA, Ghiviriga I, Sambandan TG, Rha CK, Sinskey AJ (2006) Characterization of Streptomyces MITKK-103, a newly isolated actinomycin X2-producer. Appl Microbiol Biotechnol 72:145–154

    Article  CAS  Google Scholar 

  • Lackner H, Bahner I, Shigematsu N, Pannell LK, Mauger AB (2000) Structure of five components of the actinomycin Z complex from Streptomyces fradiae, two of which contain 4-chlorothreonine. J Nat Prod 63:352–356

    Article  CAS  Google Scholar 

  • Liu XY, Ashforth E, Ren B, Song FH, Dai HQ, Liu M, Wang J, Xie Q, Zhang LX (2010) Bioprospecting microbial natural product libraries from the marine environment for drug discovery. J Antibiot 63:415–422

    Article  CAS  Google Scholar 

  • Neuwirth C, Madec S, Siebor E, Pechinot A, Duez JM, Pruneaux M, Fouchereau-Peron M, Kazmierczak A, Labia R (2001) TEM-89β-lactamase produced by a Proteus mirabilis clinical isolate: new complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3. Antimicrob Agents Chemother 45:3591–3594

    Article  CAS  Google Scholar 

  • Praveen V, Tripathi CKM (2009) Studies on the production of actinomycin-D by Streptomyces griseoruber—a novel source. Lett Appl Microbiol 49:450–455

    Article  CAS  Google Scholar 

  • Praveen V, Tripathi CKM, Bihari V (2008a) Studies on optimum fermentation conditions for actinomycin-D production by two new strains of Streptomyces spp. Med Chem Res 17:114–122

    Article  CAS  Google Scholar 

  • Praveen V, Tripathi CKM, Bihari V, Srivastava SC (2008b) Production of actinomycin-D by the mutant of a new isolate of Streptomyces sindenensis. Braz J Microbiol 39:689–692

    Article  Google Scholar 

  • Raahave D (1974) Paper disk-agar diffusion assay of penicillin in the presence of streptomycin. Antimicrob Agents Chemother 6:603–605

    Article  CAS  Google Scholar 

  • Rill RL, Hecker KH (1996) Sequence-specific actinomycin-D binding to single-stranded DNA inhibits HIV reverse transcriptase and other polymerases. Biochem 35:3525–3533

    Article  CAS  Google Scholar 

  • Saijets S, Ylipaasto P, Vaarala O, Hovi T, Roivainen M (2003) Enterovirus infection and activation of human umbilical vein endothelial cells. J Med Virol 70:430–439

    Article  Google Scholar 

  • Saitou N, Nei M (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406–425

    CAS  Google Scholar 

  • Shiojima M, Tomita H, Tanimoto K, Fujimoto S, Ike Y (1997) High-Level plasmid-mediated gentamicin resistance and pheromone response of plasmids present in clinical isolates of Enterococcus faecalis. Antimicrob Agents Chemother 41:702–705

    CAS  Google Scholar 

  • Shirling EB, Gottlieb D (1966) Methods for characterization of Streptomyces species. Int J Syst Bacteriol 16:313–340

    Article  Google Scholar 

  • Song FH, Dai HQ, Tong YJ, Ren B, Chen CX, Sun N, Liu XY, Bian J, Liu M, Gao H, Liu HW, Chen XP, Zhang LX (2010) Trichodermaketones A-D and 7-O-methylkoninginin D from the marine fungus Trichoderma koningii. J Nat Prod 73:806–810

    Article  CAS  Google Scholar 

  • Sun ZY, Yang XP (2011) The research progress of actinomycin. J Capital Normal Univ (Nat Sc Ed) 32:54–57 (in Chinese)

    CAS  Google Scholar 

  • Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 24:1596–1599

    Article  CAS  Google Scholar 

  • Thompson JD, Higgins DG, Gibson TJ (1994) ClustalW-improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673–4680

    Article  CAS  Google Scholar 

  • Wadkins RM, Vladu B, Tung CS (1998) Actinomycin D binds to metastable hairpins in single-stranded DNA. Biochem 37:11915–11923

    Article  CAS  Google Scholar 

  • Waksman SA, Tishler M (1942) The chemical nature of actinomycin, an anti-microbial substance produced by Actinomyces antibioticus. J Biol Chem 142:519–528

    CAS  Google Scholar 

  • Wang JF, Dai HQ, Wei YL, Zhu HJ, Yan YM, Wang YH, Long CL, Zhong HM, Zhang LX (2010) Antituberculosis agents and an inhibitor of the para-aminobenzoic acid biosynthetic pathway from Hydnocarpus anthelminthica seeds. Chem Biodivers 7:2046–2053

    Article  CAS  Google Scholar 

  • Womer RB (1997) Soft tissue sarcomas. Eur J Cancer 33:2230–2234

    Article  CAS  Google Scholar 

  • World Health Organization (1999) Removing obstacles to healthy development. World Health Organization, Geneva

    Google Scholar 

  • Xiong ZQ, Tu XR, Tu GQ (2008) Optimization of medium composition for actinomycin X2 production by Streptomyces spp JAU4234 using response surface methodology. J Ind Microbiol Biotechnol 35:729–734

    Article  CAS  Google Scholar 

  • You JL, Dai HQ, Chen ZH, Liu GJ, He ZX, Song FH, Yang X, Fu HA, Zhang LX, Chen XP (2010) Trichoderone, a novel cytotoxic cyclopentenone and cholesta-7, 22-diene-3β, 5α, 6β-triol with new activities from the marine-derived fungus Trichoderma sp. J Ind Microbiol Biotechnol 37:245–252

    Article  CAS  Google Scholar 

  • Yu C, Tseng Y (1992) NMR study of the solution conformation of actinomycin D. Eur J Biochem 209:181–187

    Article  CAS  Google Scholar 

  • Yu K, Ren B, Wei JL, Chen CX, Song FH, Dai HQ, Zhang LX (2010) Verrucisidin A and B, two prone-type polyketides isolated from a marine derived fungus, Penicillium aurantiogriseum. Marine Drugs 8:2744–2754

    Article  CAS  Google Scholar 

  • Zhang LX, An R, Wang JP, Sun N, Zhang S, Hu JC, Kuai J (2005) Exploring novel bioactive compounds from marine microbes. Curr Opin Microbiol 8:276–281

    Article  CAS  Google Scholar 

  • Zhang LX, Yan KZ, Zhang Y, Huang R, Bian J, Zheng CS, Sun HX, Sun N, An R, Min FG, Zhang WB, Zhuo Y, You JL, Song YJ, Yu ZY, Liu ZH, Yang HK, Gao H, Dai HQ, Zhang XL, Wang J, Fu CZ, Pei G, Liu JT, Zhang S, Goodfellow M, Jiang YY, Kuai J, Zhou GC, Chen XP (2007) High throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. Proc Natl Acad Sci 104:4606–4611

    Article  CAS  Google Scholar 

  • Zhang Z, Peng G, Yang G, Xiao CL, Hao XQ (2009) Isolation, purification, identification of structures and study of bioactivity of anti-TB active component 9005B. Chin J Antibiot 34:399–402

    CAS  Google Scholar 

  • Zhuo Y, Zhang WQ, Chen DF, Gao H, Tao J, Liu M, Gou ZX, Zhou XL, Wang Q, Ye B, Zhang Q, Zhang S, Zhang LX (2010) Reverse biological engineering of hrdB to enhance the production of avermectins in an industrial strain of Streptomyces avermitilis. Proc Natl Acad Sci 107:11250–11254

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This research was partly supported by the National Natural Science Foundation of China (30973665, 30911120483, 30911120484, 81102356, and 81102369), the CAS Pillar Program (XDA04074000), the Ministry of Science and Technology of China (2007DFB31620, 2011ZX09102-011-11, 2012CB721006), and China Postdoctoral Science Foundation (49th). L. Z. is an Awardee for National Distinguished Young Scholar Program in China.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Ruxian Chen or Lixin Zhang.

Additional information

Caixia Chen, Fuhang Song, and Qian Wang contributed equally to this paper.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(PDF 72 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, C., Song, F., Wang, Q. et al. A marine-derived Streptomyces sp. MS449 produces high yield of actinomycin X2 and actinomycin D with potent anti-tuberculosis activity. Appl Microbiol Biotechnol 95, 919–927 (2012). https://doi.org/10.1007/s00253-012-4079-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00253-012-4079-z

Keywords

Navigation